Medicare Enrolled

Dr. Flint Deshazo, M.D.

Family Medicine · Round Rock, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
7200 WYOMING SPGS, Round Rock, TX 78681
5122441995
In practice since 2005 (20 years)
NPI: 1669474623 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Deshazo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deshazo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Deshazo

Dr. Flint Deshazo is a family medicine in Round Rock, TX, with 20 years in practice. Based on federal Medicare data, Dr. Deshazo performed 2,640 Medicare services across 1,950 unique beneficiaries.

Between the years covered by Open Payments, Dr. Deshazo received a total of $19,941 from 72 pharmaceutical and/or device companies across 1392 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Deshazo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 9% volume in TX$ $19,941 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,640
Medicare services
Top 9% in TX for family medicine
1,950
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~132 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)465$76$195
Blood draw (venipuncture)265$8$19
Complete blood count (CBC) with differential218$8$31
Lipid panel (cholesterol and triglycerides)201$13$53
Comprehensive metabolic blood panel184$10$38
Thyroid stimulating hormone (TSH) test174$16$94
Automated urinalysis152$2$13
Annual wellness visit, follow-up113$124$154
Hemoglobin A1c test (diabetes monitoring)111$10$51
Vitamin D level test73$29$40
Office visit, established patient (20-29 min)72$53$135
Basic metabolic blood panel63$8$31
Prostate cancer screening; prostate specific antigen test (psa)62$19$77
Testosterone (hormone) level, total58$25$119
Detection test by immunoassay with direct visual observation for influenza virus58$16$60
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage55$22$57
Electrocardiogram (EKG), 12-lead54$8$76
Uric acid level test52$4$16
Flu vaccine administration49$30$50
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus37$35$82
Liver function blood test panel33$8$143
Office visit, established patient, complex (40-54 min)28$129$300
Glutamyltransferase (liver enzyme) level15$7$33
Iron level test13$6$29
Urine microalbumin test (kidney screening)12$6$69
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)12$16$32
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment11$158$217
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,941
Total received (2018-2024)
Avg $2,849/year across 7 years
Top 1% in TX for family medicine
72
Companies
1,392
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,749 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$193 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,550
2023
$2,829
2022
$2,848
2021
$2,905
2020
$2,576
2019
$3,318
2018
$2,916

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,872
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,872
Novo Nordisk Inc
$1,679
Lilly USA, LLC
$1,277
GlaxoSmithKline, LLC.
$1,143
Janssen Pharmaceuticals, Inc
$1,051
Amarin Pharma Inc.
$952
AbbVie Inc.
$805
Amgen Inc.
$745
Antares Pharma, Inc.
$731
Abbott Laboratories
$582
Amneal Pharmaceuticals LLC
$498
PFIZER INC.
$445
ABBVIE INC.
$428
Merck Sharp & Dohme Corporation
$409
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$326
Biohaven Pharmaceuticals, Inc.
$292
Astellas Pharma US Inc
$290
Takeda Pharmaceuticals U.S.A., Inc.
$289
Corium, LLC
$268
ARBOR PHARMACEUTICALS, INC.
$220
Genentech USA, Inc.
$187
AbbVie, Inc.
$173
Allergan, Inc.
$166
Supernus Pharmaceuticals, Inc.
$154
Exact Sciences Corporation
$106
SANOFI-AVENTIS U.S. LLC
$104
IDORSIA PHARMACEUTICALS US INC
$97
Ironshore Pharmaceuticals Inc.
$89
Tris Pharma Inc
$88
Teva Pharmaceuticals USA, Inc.
$82
Axsome Therapeutics, Inc.
$82
IBSA Pharma Inc.
$81
Bausch Health US, LLC
$78
Bayer Healthcare Pharmaceuticals Inc.
$73
Neos Therapeutics, LP
$73
Shire North American Group Inc
$69
Novartis Pharmaceuticals Corporation
$68
Allergan Inc.
$68
Biohaven Pharmaceutical Holding Company Ltd.
$64
Gemini Laboratories, LLC
$59
Adlon Therapeutics L.P.
$57
Endo Pharmaceuticals Inc.
$52
Acerus Pharmaceuticals Corporation
$52
UPSHER-SMITH LABORATORIES LLC
$46
Arbor Pharmaceuticals, Inc.
$40
Aytu BioScience, Inc
$39
Esperion Therapeutics, Inc.
$38
Shield Therapeutics Inc
$37
Medtronic, Inc.
$34
Eisai Inc.
$32
Horizon Therapeutics plc
$26
Otsuka America Pharmaceutical, Inc.
$23
Itamar Medical Inc
$23
Phathom Pharmaceuticals, Inc.
$23
Lundbeck LLC
$22
Jazz Pharmaceuticals Inc.
$21
Clarus Therapeutics Inc.
$19
Noven Therapeutics, LLC
$19
SHIELD THERAPEUTICS INC
$19
Currax Pharmaceuticals LLC
$17
Tolmar, Inc.
$17
Radius Health, Inc.
$17
Avanir Pharmaceuticals, Inc.
$17
Althera Pharmaceuticals LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
BioDelivery Sciences International, Inc.
$16
Dexcom, Inc.
$15
Medicure Pharma Inc.
$15
Xeris Pharmaceuticals, Inc.
$14
VBI Vaccines (Delaware) Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 32.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADHANSIA XR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · AREXVY · ASMANEX · AVEED · AZSTARYS · Adzenys XR-ODT · Aimovig · Auvelity · Azstarys · BASAGLAR · BELBUCA · BELSOMRA · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CHANTIX · COMIRNATY · CONTRAVE · Cologuard Collection Kit · DUEXIS · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GLYXAMBI · GVOKE HYPOPEN · HUMALOG · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · Kerendia · LICART · LINZESS · LYRICA · Licart · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NEXPLANON · NOCDURNA · NURTEC ODT · Natesto · OCTRODE · ONZETRA Xsail · OTREXUP · Otezla · Otovel · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PROCLAIM · PreHevbrio · Prolia · QELBREE · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SUNOSI · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TLANDO · TOSYMRA · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · UNITHROID · VANTA ADAPTIVESTIM · VOQUEZNA · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Victoza · WELLBUTRIN · WatchPATONE · Wegovy · XARELTO · XIAFLEX · XIFAXAN · XYOSTED · Xelstrym · Xofluza · Xultophy 100/3.6 · ZEPBOUND · ZOMIG · Zypitamag
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in TX.

Equivalent to $755 per 100 Medicare services performed
Looking for a family medicine in Round Rock?
Compare family medicines in the Round Rock area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
761
Per 100K population
118.2
County median income
$108,309
Nearest hospital
ROUND ROCK MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Deshazo is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (low-engagement, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Deshazo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Deshazo performed 465 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deshazo receive payments from pharmaceutical companies?
Yes. Dr. Deshazo received a total of $19,941 from 72 companies across 1,392 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deshazo's costs compare to other family medicines in Round Rock?
Dr. Deshazo's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deshazo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →